Autologous CD33-CAR-T cells for treatment of relapsed/refractory acute myelogenous leukemia.

ABSTRACT:

SUBMITTER: Tambaro FP 

PROVIDER: S-EPMC8550958 | biostudies-literature | 2021 Nov

REPOSITORIES: biostudies-literature